Compound ID | 3228
Synonym(s): HR-810 | HR810
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Enterobacter cloacae, Streptococcus sp., Pseudomonas aeruginosa |
| Description: | A fourth-generation synthetic compound derived from cephalosporin C; shows synergistic effect with gentamicin in Pseudomonas and Enterobacter strains |
| Institute where first reported: | Hoechst AG |
| Year first mentioned: | 1983 |
| Highest developmental phase: | Approved (not in US) |
| Development status: | Approved |
| Reason Dropped: | Discontinued in many countries |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5479539 |
| Guide to Pharmacology: | cefpirome |
| Citations: |
|